Condition
Transplant; Complication, Failure
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Unknown1
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06504225RecruitingPrimary
EVEROLD LONG TERM FOLLOW-UP
NCT04848844Recruiting
The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
NCT05469906Not Yet RecruitingPrimary
Evaluation at 5 and 10 Years of Renal Transplant Patients
NCT05050513UnknownPrimary
Evaluation of HEMO2Life® for Kidney Graft Preservation (OXYOP): 4 Years Follow-up
NCT03893656CompletedPrimary
Retroperitoneoscopic Donor Nephrectomy
Showing all 5 trials